Interferon-γ receptors on human gestational choriocarcinoma cell lines: Quantitative and functional studies

V. Fülöp, M. A. Steller, R. S. Berkowitz

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objectives: This study was performed to further define the effects of interferon-γ on choriocarcinoma cell lines and to determine whether variations in response among cell lines are attributable to quantitative differences in interferon-γ receptors. Study design: Interferon-γ receptors were quantified on BeWo, JEG-3 and Jar choriocarcinoma cell lines by a radiolabeled interferon-γ ligand binding assay. The response of these cell lines to interferon-γ was measured in two functional assays: a cell proliferation assay and a cell lysis assay after exposure to interferon-γ with and without actinomycin-D. Results: The number of interferon-γ receptors on BeWo, Jar, and JEG-3 cells did not differ significantly (650, 560, and 420 interferon-γ receptors per cell, respectively). Proliferation of all three choriocarcinoma cell lines was significantly inhibited to a similar extent by interferon-γ. After treatment with interferon-γ actinomycin-D, each choriocarcinoma cell line exhibited dose-dependent cell lysis; lysis of Jar was significantly less than that of either BeWo or JEG-3. Conclusion: These data further document variations in the response of choriocarcinoma cell lines to interferon-γ and indicate that these differences are not the result of interferon-γ receptor number but of postreceptor mechanisms.

Original languageEnglish
Pages (from-to)524-530
Number of pages7
JournalAmerican Journal of Obstetrics and Gynecology
Volume167
Issue number2
Publication statusPublished - 1992

Fingerprint

Interferon Receptors
Choriocarcinoma
Interferons
Cell Line
Dactinomycin
Cell Proliferation
Ligands

Keywords

  • choriocarcinoma
  • inferon-γ
  • receptors

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynaecology

Cite this

Interferon-γ receptors on human gestational choriocarcinoma cell lines : Quantitative and functional studies. / Fülöp, V.; Steller, M. A.; Berkowitz, R. S.

In: American Journal of Obstetrics and Gynecology, Vol. 167, No. 2, 1992, p. 524-530.

Research output: Contribution to journalArticle

@article{b0a87a3a9a4f4048853fc0c5c260c95b,
title = "Interferon-γ receptors on human gestational choriocarcinoma cell lines: Quantitative and functional studies",
abstract = "Objectives: This study was performed to further define the effects of interferon-γ on choriocarcinoma cell lines and to determine whether variations in response among cell lines are attributable to quantitative differences in interferon-γ receptors. Study design: Interferon-γ receptors were quantified on BeWo, JEG-3 and Jar choriocarcinoma cell lines by a radiolabeled interferon-γ ligand binding assay. The response of these cell lines to interferon-γ was measured in two functional assays: a cell proliferation assay and a cell lysis assay after exposure to interferon-γ with and without actinomycin-D. Results: The number of interferon-γ receptors on BeWo, Jar, and JEG-3 cells did not differ significantly (650, 560, and 420 interferon-γ receptors per cell, respectively). Proliferation of all three choriocarcinoma cell lines was significantly inhibited to a similar extent by interferon-γ. After treatment with interferon-γ actinomycin-D, each choriocarcinoma cell line exhibited dose-dependent cell lysis; lysis of Jar was significantly less than that of either BeWo or JEG-3. Conclusion: These data further document variations in the response of choriocarcinoma cell lines to interferon-γ and indicate that these differences are not the result of interferon-γ receptor number but of postreceptor mechanisms.",
keywords = "choriocarcinoma, inferon-γ, receptors",
author = "V. F{\"u}l{\"o}p and Steller, {M. A.} and Berkowitz, {R. S.}",
year = "1992",
language = "English",
volume = "167",
pages = "524--530",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Interferon-γ receptors on human gestational choriocarcinoma cell lines

T2 - Quantitative and functional studies

AU - Fülöp, V.

AU - Steller, M. A.

AU - Berkowitz, R. S.

PY - 1992

Y1 - 1992

N2 - Objectives: This study was performed to further define the effects of interferon-γ on choriocarcinoma cell lines and to determine whether variations in response among cell lines are attributable to quantitative differences in interferon-γ receptors. Study design: Interferon-γ receptors were quantified on BeWo, JEG-3 and Jar choriocarcinoma cell lines by a radiolabeled interferon-γ ligand binding assay. The response of these cell lines to interferon-γ was measured in two functional assays: a cell proliferation assay and a cell lysis assay after exposure to interferon-γ with and without actinomycin-D. Results: The number of interferon-γ receptors on BeWo, Jar, and JEG-3 cells did not differ significantly (650, 560, and 420 interferon-γ receptors per cell, respectively). Proliferation of all three choriocarcinoma cell lines was significantly inhibited to a similar extent by interferon-γ. After treatment with interferon-γ actinomycin-D, each choriocarcinoma cell line exhibited dose-dependent cell lysis; lysis of Jar was significantly less than that of either BeWo or JEG-3. Conclusion: These data further document variations in the response of choriocarcinoma cell lines to interferon-γ and indicate that these differences are not the result of interferon-γ receptor number but of postreceptor mechanisms.

AB - Objectives: This study was performed to further define the effects of interferon-γ on choriocarcinoma cell lines and to determine whether variations in response among cell lines are attributable to quantitative differences in interferon-γ receptors. Study design: Interferon-γ receptors were quantified on BeWo, JEG-3 and Jar choriocarcinoma cell lines by a radiolabeled interferon-γ ligand binding assay. The response of these cell lines to interferon-γ was measured in two functional assays: a cell proliferation assay and a cell lysis assay after exposure to interferon-γ with and without actinomycin-D. Results: The number of interferon-γ receptors on BeWo, Jar, and JEG-3 cells did not differ significantly (650, 560, and 420 interferon-γ receptors per cell, respectively). Proliferation of all three choriocarcinoma cell lines was significantly inhibited to a similar extent by interferon-γ. After treatment with interferon-γ actinomycin-D, each choriocarcinoma cell line exhibited dose-dependent cell lysis; lysis of Jar was significantly less than that of either BeWo or JEG-3. Conclusion: These data further document variations in the response of choriocarcinoma cell lines to interferon-γ and indicate that these differences are not the result of interferon-γ receptor number but of postreceptor mechanisms.

KW - choriocarcinoma

KW - inferon-γ

KW - receptors

UR - http://www.scopus.com/inward/record.url?scp=0026706408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026706408&partnerID=8YFLogxK

M3 - Article

C2 - 1386713

AN - SCOPUS:0026706408

VL - 167

SP - 524

EP - 530

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 2

ER -